Press Releases
Washington, D.C. (May 18, 2021)—Below is Committee on Oversight and Reform Chairwoman Carolyn B. Maloney's opening statement, as prepared for delivery, for today's full committee hearing examining the pricing and business practices of AbbVie Inc., which sells the anti-inflammatory drug Humira and the cancer drug Imbruvica.
Washington, D.C. (May 18, 2021)—Today, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, issued the following statement after releasing a staff report with new documents and details about AbbVie Inc., which sells the anti-inflammatory drug Humira and the cancer drug Imbruvica. AbbVie has repeatedly raised the prices of these two blockbuster drugs:
Washington D.C. (May 17, 2021)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, and Rep. Bennie G. Thompson, the Chairman of the Committee on Homeland Security, issued the following statement after today's joint staff briefing with Colonial Pipeline:
Washington, D.C. (May 14, 2021)— Today, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, issued the following statement in response to a new report from the Department of Homeland Security Inspector General entitled, "CBP Senior Leaders' Handling of Social Media Misconduct":
Washington D.C. (May 14, 2021)—On Tuesday, May 18, 2021, at 10:00 a.m., Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, will hold a hybrid hearing to examine the pricing and business practices of AbbVie Inc., which sells the anti-inflammatory drug Humira and the cancer drug Imbruvica.
Washington D.C. (May 13, 2021)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, issued the following statement after the Committee voted favorably to send several good government bills to the House Floor:
Washington, D.C. (May 13, 2021) — Today, Rep. James E.
Washington D.C. (May 13, 2021)—Today, the Committee on Oversight and Reform passed the bipartisan Postal Service Reform Act, a bill that would place the Postal Service on a more sustainable financial footing, on a voice vote.
Chairwoman of the Committee on Oversight and Reform Carolyn B. Maloney and Ranking Member James Comer issued the following statements celebrating passage of the landmark legislation:
Washington D.C. (May 13, 2021)— On Tuesday, June 8, 2021, at 10:00 a.m. E.T., Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, will hold a hybrid hearing to examine the Sackler family's role in fueling America's opioid epidemic and policies to promote accountability, like the SACKLER Act.
Washington, D.C. (May 13, 2021)—Below is Committee on Oversight and Reform Chairwoman Carolyn B. Maloney's opening statement about the Federal Advisory Committee Transparency Act, as prepared for delivery, for today's hybrid business meeting.